EAPM - Time to register for key personalised medicine conference on 12 October - register now!

Registration is still open for the European Alliance for Personalised Medicine (EAPM) conference entitled 'Ensuring Access to Innovation and data-rich biomarker space to speed better quality of care for Citizens in a COVID 19 and Post-COVID 19 world', taking place during the Germany EU Presidency conference which will be a ‘virtual’ event, held online, on 12 October, writes EAPM Executive Director Denis Horgan. 

Please find the link here to register and the agenda is here.

The Alliance has helped to shape awareness among stakeholders and policymakers over recent years about the needs of modern-day patients, and about the potential of personalised medicine to change healthcare for the better. 

Now, in a world where the landscape has been changed not just by massive advances in science and technology but by the COVID 19 pandemic and the consequent shift in perceptions of the place in health in society, EAPM focused in this latest conference on how more of that “future promise” can be integrated into current clinical practice and health system strategy.

There is potential future promise in the European policy context, with the legislative and policy initiatives currently on the EU agenda. 

The Beating Cancer Plan and the Cancer Mission, the European Health Data Space, the expanded health programme, the review of research incentives and – most recently – the declaration of Commission President Ursula von der Leyen in favour of European Health Union. But for all these potential positives to be realized, it will be necessary to establish a co-created framework involving all stakeholders, and for clear messages to be transmitted from clinical, research and patient communities to policymakers in government, among payers, and in health technology assessment bodies.

To perfectly match the less-than-perfect times we find ourselves in through social distancing, the conference will be socially connected virtually.

Please find the link here to register and the agenda is here. 

So, what are among the topics on the table?

The current COVID-19 crisis has thrown many European, and indeed global, health-care issues into sharp relief.

It has also raised important questions, not necessarily new ones, but ones that have shifted more into focus during the pandemic.

One such question is whether the EU should have a bigger role in public health – and particularly in the provision of health technology. This, of course, would impinge upon the closely guarded member state competence in health care so, if this were to happen, how would that be?

Sessions during the presidency conference will address topics such as:

• Opening Session: The Pharmaceutical Strategy of the EU: Developing a Framework to ensure capacity and equitability across the EU
• Session I: Multi-stakeholder approach – Rational Allocation of Resources to support innovation and healthcare system efficiencies – Who to test, when to test and how to test?
• Session II: Cancer: Case Study for EU Coordinated Action on Prostate, Lung, Breast and Cervical Cancer
  
• Session III: Biomarker testing: Piercing the fog of Alzheimer's and related dementia
  
• Session IV: Propelling Healthcare with Advanced Therapy Medicinal Products (ATMPs)
  
•  Closing Session: Realising the potential of Data & Early Diagnosis through biomarker testing & Molecular Diagnostics

Please find the link here to register and the agenda is here. The above are just an example of the huge topics among many up for discussion on the day. So be sure to join us on 12 October.

Therefore, if you are a stakeholder in personalised medicine in particular, or the advancement of healthcare in general, this is the ideal forum for sharing your views and expertise while absorbing that of others.

 We hope to see you in virtually on 12 October!

Share this article: